fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Patients drop MS drug, face relapse risk

Written by | 2 May 2012

A study of discontinuing natalizumab for multiple sclerosis patients testing positive for JC virus antibody found a higher relapse rate within 6 months than for patients continuing the… read more.

Discovery could help to develop drugs for organ transplant and cancer patients

Written by | 23 Apr 2012

Loyola researchers are reporting surprising findings about a molecule that helps ramp up the immune system in some cases and suppress it in others.  The finding eventually could… read more.

ESMO 2011 Report – How safe is chemotherapy during pregnancy?

Written by | 16 Apr 2012

by Dr Sunil Upadhyay – The overall incidence of cancer is known to increase with age. However, there is hardly any age group that can be spared from… read more.

BTS 2012 Report – Pathways of MHC Allorecognition

Written by | 28 Mar 2012

by Maria Dalby reporting on the presentation by Robert Lechler, King’s College Hospital, London.  Understanding how a transplant recipient’s immune system recognises the alloantigens that trigger rejection is… read more.

BTS 2012 Report – Assessing the true cost of transplantation

Written by | 28 Mar 2012

by Maria Dalby – Introduction – Recent advances in transplant medicine and surgery mean more lives can be saved or prolonged with an organ transplantation, but also that… read more.

Genital herpes can reactivate even during high dose antiviral therapy

Written by | 16 Mar 2012

Taken from The Lancet – by Bruce Sylvester – A new evaluation of data from three trials of antiviral therapy to treat genital herpes (herpes simplex virus type… read more.

UK experts: paediatric penicillin dosing guidelines need updating

Written by | 16 Mar 2012

Taken from the British Medical Journal (BMJ) – by Bruce Sylvester – A Study published on Dec. 20, 2011 in the British Medical Journal suggests that some children… read more.

Public consultation on cancer medicines

Written by | 16 Mar 2012

EMA Highlights by Gary Finnegan – The EMA has launched a public consultation on its revised guidelines covering how potential cancer drugs are assessed.  The document provides guidance… read more.

Tighter regulation promised after breast implant scandal

Written by | 16 Mar 2012

EMA Highlights by Gary Finnegan – The new head of the European Medicines Agency, Guido Rasi, has promised to strengthen European rules governing medical devices in the wake… read more.

Drug focus on diabetes

Written by | 16 Mar 2012

It is estimated that there are 2.9 million people in the UK diagnosed with diabetes1 and the incidence is increasing, as it is across the world, all the… read more.

Clot-busting therapy effective for patients with stroke history or diabetes

Written by | 16 Mar 2012

by Bruce Sylvester – Stroke patients with a history of stroke or diabetes who received clot-busting drugs post-stroke have achieved better outcomes than those who did not receive… read more.

ASCO 2011 Report – Thoracic oncology update

Written by | 16 Mar 2012

by Dr. Riyaz Shah, Consultant Medical Oncologist, Kent Oncology Centre – The ASCO 2011 Annual Meeting took place in early June at the vast McCormick Place Convention Centre… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.